Net Profit Margin
since 2005
Calculation
Edwards Lifesciences Corp., net profit margin, long-term trends, calculation
| Net profit margin | = | 100 | × | Net income1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2021 | 28.73% | = | 100 | × | 1,503,100) | ÷ | 5,232,500) |
| Dec 31, 2020 | 18.77% | = | 100 | × | 823,400) | ÷ | 4,386,300) |
| Dec 31, 2019 | 24.08% | = | 100 | × | 1,046,900) | ÷ | 4,348,000) |
| Dec 31, 2018 | 19.40% | = | 100 | × | 722,200) | ÷ | 3,722,800) |
| Dec 31, 2017 | 16.99% | = | 100 | × | 583,600) | ÷ | 3,435,300) |
| Dec 31, 2016 | 19.22% | = | 100 | × | 569,500) | ÷ | 2,963,700) |
| Dec 31, 2015 | 19.85% | = | 100 | × | 494,900) | ÷ | 2,493,700) |
| Dec 31, 2014 | 34.92% | = | 100 | × | 811,100) | ÷ | 2,322,900) |
| Dec 31, 2013 | 19.15% | = | 100 | × | 391,700) | ÷ | 2,045,500) |
| Dec 31, 2012 | 15.43% | = | 100 | × | 293,200) | ÷ | 1,899,600) |
| Dec 31, 2011 | 14.10% | = | 100 | × | 236,700) | ÷ | 1,678,600) |
| Dec 31, 2010 | 15.07% | = | 100 | × | 218,000) | ÷ | 1,447,000) |
| Dec 31, 2009 | 17.34% | = | 100 | × | 229,100) | ÷ | 1,321,400) |
| Dec 31, 2008 | 10.41% | = | 100 | × | 128,900) | ÷ | 1,237,700) |
| Dec 31, 2007 | 10.36% | = | 100 | × | 113,000) | ÷ | 1,091,100) |
| Dec 31, 2006 | 12.58% | = | 100 | × | 130,500) | ÷ | 1,037,000) |
| Dec 31, 2005 | 7.95% | = | 100 | × | 79,300) | ÷ | 997,900) |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in thousands
The company demonstrated consistent growth in both top-line revenue and net income from 2005 to 2021. Net sales expanded from US$ 997.9 million to US$ 5.23 billion, while net income rose from US$ 79.3 million to US$ 1.5 billion. This expansion reflects a scalable business model where net profitability grew at a faster rate than overall revenue.
- Initial Margin Performance (2005–2008)
- During the earliest period analyzed, net profit margins remained relatively low and stable, ranging from 7.95% to 12.58%. This phase characterizes a period of steady growth with modest profitability relative to total sales.
- Expansion and Margin Acceleration (2009–2013)
- A notable shift occurred in 2009, as the net profit margin increased to 17.34%. For the subsequent few years, profitability generally trended upward, reaching 19.15% by 2013, which suggests improved operational efficiencies or a shift toward higher-margin offerings.
- Peak Profitability and Subsequent Correction (2014–2018)
- The year 2014 witnessed a significant spike in the net profit margin to 34.92%, representing the highest peak in the observed timeframe. This was followed by a correction in 2015, where the margin returned to 19.85%. Between 2015 and 2018, the margin stabilized, fluctuating within a range of 16.99% to 19.85%.
- Recent Profitability Trends (2019–2021)
- In the final three years of the period, profitability showed increased volatility but an overall upward trajectory. After reaching 24.08% in 2019, the margin dipped to 18.77% in 2020 before climbing to 28.73% in 2021. This indicates a strong recovery and a sustained ability to convert sales into net profit at rates significantly higher than those seen in the first decade of the analysis.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Comparison to Competitors
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to competitors
| Edwards Lifesciences Corp. | Abbott Laboratories | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
|---|---|---|---|---|---|---|
| Dec 31, 2021 | 28.73% | 16.42% | 4.46% | 29.85% | 11.97% | 6.06% |
| Dec 31, 2020 | 18.77% | 12.99% | 3.78% | 24.33% | 16.56% | 6.03% |
| Dec 31, 2019 | 24.08% | 11.56% | 4.66% | 30.80% | 15.16% | 5.76% |
| Dec 31, 2018 | 19.40% | 7.74% | 4.11% | 30.29% | 10.36% | 5.33% |
| Dec 31, 2017 | 16.99% | 1.74% | 4.31% | 21.09% | 13.56% | 5.28% |
| Dec 31, 2016 | 19.22% | 6.71% | 2.93% | 27.21% | 12.27% | 3.81% |
| Dec 31, 2015 | 19.85% | 21.68% | 3.27% | 24.69% | 13.20% | 3.72% |
| Dec 31, 2014 | 34.92% | 11.28% | 3.52% | 19.65% | 18.02% | 4.33% |
| Dec 31, 2013 | 19.15% | 11.79% | 3.55% | 29.62% | 20.90% | 4.62% |
| Dec 31, 2012 | 15.43% | 14.95% | 4.37% | 30.14% | 22.35% | 5.03% |
| Dec 31, 2011 | 14.10% | 12.17% | 4.42% | 28.17% | 19.43% | 5.08% |
| Dec 31, 2010 | 15.07% | 13.15% | 4.99% | 27.02% | 19.59% | 4.95% |
| Dec 31, 2009 | 17.34% | 18.68% | 7.80% | 22.11% | 14.86% | 4.42% |
| Dec 31, 2008 | 10.41% | 16.53% | 4.04% | 23.35% | 16.51% | 3.70% |
| Dec 31, 2007 | 10.36% | 13.92% | 5.56% | 24.06% | 22.78% | 6.26% |
| Dec 31, 2006 | 12.58% | 7.64% | 5.52% | 19.33% | 22.55% | 5.89% |
| Dec 31, 2005 | 7.95% | 15.10% | 5.53% | 41.41% | 17.94% | 7.36% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to sector (health care equipment & services)
| Edwards Lifesciences Corp. | Health Care Equipment & Services | |
|---|---|---|
| Dec 31, 2021 | 28.73% | 7.14% |
| Dec 31, 2020 | 18.77% | 6.82% |
| Dec 31, 2019 | 24.08% | 6.91% |
| Dec 31, 2018 | 19.40% | 5.87% |
| Dec 31, 2017 | 16.99% | 5.60% |
| Dec 31, 2016 | 19.22% | 4.73% |
| Dec 31, 2015 | 19.85% | 5.78% |
| Dec 31, 2014 | 34.92% | 5.76% |
| Dec 31, 2013 | 19.15% | 6.37% |
| Dec 31, 2012 | 15.43% | 8.05% |
| Dec 31, 2011 | 14.10% | 7.40% |
| Dec 31, 2010 | 15.07% | 7.67% |
| Dec 31, 2009 | 17.34% | 8.63% |
| Dec 31, 2008 | 10.41% | 6.88% |
| Dec 31, 2007 | 10.36% | 8.40% |
| Dec 31, 2006 | 12.58% | 7.20% |
| Dec 31, 2005 | 7.95% | 9.04% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Edwards Lifesciences Corp., net profit margin, long-term trends, comparison to industry (health care)
| Edwards Lifesciences Corp. | Health Care | |
|---|---|---|
| Dec 31, 2021 | 28.73% | 15.24% |
| Dec 31, 2020 | 18.77% | 10.27% |
| Dec 31, 2019 | 24.08% | 14.56% |
| Dec 31, 2018 | 19.40% | 12.61% |
| Dec 31, 2017 | 16.99% | 9.26% |
| Dec 31, 2016 | 19.22% | 12.80% |
| Dec 31, 2015 | 19.85% | 13.94% |
| Dec 31, 2014 | 34.92% | 14.40% |
| Dec 31, 2013 | 19.15% | 15.04% |
| Dec 31, 2012 | 15.43% | 13.92% |
| Dec 31, 2011 | 14.10% | 12.06% |
| Dec 31, 2010 | 15.07% | 11.90% |
| Dec 31, 2009 | 17.34% | 17.77% |
| Dec 31, 2008 | 10.41% | 13.00% |
| Dec 31, 2007 | 10.36% | 12.52% |
| Dec 31, 2006 | 12.58% | 15.30% |
| Dec 31, 2005 | 7.95% | 14.61% |
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).